This study is a non-drug follow up study to A3051123 for cardiac assessments after use of smoking cessation treatments

Update Il y a 4 ans
Reference: EUCTR2011-005513-37

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the CV safety assessment will be to characterize the cardiovascular safety profiles of varenicline and bupropion compared to placebo.


Inclusion criteria

  • Nicotine Addiction with the desire to quit smoking